基因名 | 疾病 | 靶向药 | 化疗药 | 基因突变 | 临床解释 |
---|---|---|---|---|---|
TP53 | 急性髓细胞白血病,肾上腺皮质癌,乳腺癌,癌症,宫颈癌,慢性淋巴细胞白血病,CLL/SLL,结直肠癌,食管癌,食管鳞状细胞癌,胃腺癌,头颈鳞状细胞癌,白血病,李夫琅梅尼综合征,肺腺癌癌细胞瘤,肺癌,非小细胞肺癌,淋巴瘤,骨髓增生异常综合征,骨髓瘤,神经母细胞瘤,少突胶质瘤,口腔鳞状细胞癌,卵巢癌,前体B淋巴细胞淋巴瘤/白血病,唾液腺粘液腺癌,肉瘤,皮肤鳞状细胞癌,胃癌胃癌,华登斯特巨球蛋白血症 | Adjuvant Chemotherapy,阿仑单抗,AMGMDS3,硼替佐米,卡培他滨,西妥昔单抗,Chemotherapy,EAP Protocol,Nutlin-3a,帕唑帕尼,培唑帕尼,RG7112,司美替尼,维莫非尼,维奈妥拉/维耐托克, | 卡铂,顺铂,多西他赛,多柔比星,依托泊苷,丝裂霉素,奥沙利铂,他莫昔芬, | 53 | 138 |
TERT | Acral扁豆状黑色素瘤,脑胶质瘤,透明细胞肾细胞癌,多形胶质母细胞瘤,乳头状甲状腺癌,儿童低级别胶质瘤(PLGG),皮肤黑色素瘤,甲状腺癌 | I-131,U0126, | 5 | 15 | |
TYMS | 癌症,结直肠癌,胃腺癌,肺腺癌,非小细胞肺癌,前列腺癌 | 氟尿嘧啶,伊立替康,甲氨蝶呤,培美曲塞,雷替曲塞, | 5 | 8 | |
TSC1 | 膀胱癌,浸润性膀胱移行细胞癌,非小细胞肺癌,肾细胞癌,结节性硬化症 | 依维莫司,MTOR Inhibitors,西罗莫司, | 3 | 8 | |
TOP1 | 结直肠癌,卵巢癌 | 卡铂,环磷酰胺,伊立替康,拓扑替康, | 2 | 3 | |
TSC2 | 肾细胞癌,甲状腺癌,结节性硬化 | 依维莫司,MTOR Inhibitors, | 2 | 3 | |
TET2 | 急性髓性白血病,骨髓增生异常综合征 | 1 | 6 | ||
TTF1 | 肺腺癌 | 1 | 1 | ||
TF | 黑色素瘤 | 维莫非尼, | 1 | 1 | |
TFF3 | 乳腺癌 | 氨鲁米特,他莫昔芬, | 1 | 1 | |
TGFA | 头颈部鳞状细胞癌 | 1 | 1 | ||
TGFBR3 | 前列腺癌 | 1 | 1 | ||
THBS2 | 结直肠癌 | 1 | 1 | ||
TIMP1 | 乳腺癌 | 氟维司群, | 紫杉醇, | 1 | 2 |
TOP2A | 乳腺癌 | 多柔比星, | 1 | 1 | |
TPT1 | 黑色素瘤 | Sertraline (INN), | 1 | 1 | |
TSPYL1 | 前列腺癌 | 1 | 1 | ||
TUBB3 | 乳腺癌,癌症 | Taxane, | 紫杉醇, | 1 | 2 |
TLK2 | 乳腺癌 | GF109203X,Go6983, | 1 | 1 | |
TBK1 | 黑色素瘤 | AZ909,司美替尼, | 1 | 1 | |
TAF1 | 0 | 0 | |||
TGFBR2 | 0 | 0 | |||
TNFRSF14 | 0 | 0 | |||
TEK | 0 | 0 | |||
TMEM127 | 0 | 0 | |||
TSHR | 0 | 0 | |||
TNFAIP3 | 0 | 0 | |||
TMPRSS2 | 0 | 0 | |||
TPMT | 0 | 0 | |||
TBX3 | 0 | 0 | |||
TNF | 0 | 0 | |||
TAP1 | 0 | 0 | |||
TAP2 | 0 | 0 | |||
TCF3 | 0 | 0 | |||
TCF4 | 0 | 0 | |||
TCF7L2 | 0 | 0 | |||
TDO2 | 0 | 0 | |||
TEKT4 | 0 | 0 | |||
TERC | 0 | 0 | |||
TET1 | 0 | 0 | |||
TFE3 | 0 | 0 | |||
TGFBR1 | 0 | 0 | |||
TIPARP | 0 | 0 | |||
TLR4 | 0 | 0 | |||
TNFRSF11A | 0 | 0 | |||
TNFSF11 | 0 | 0 | |||
TNKS | 0 | 0 | |||
TNKS2 | 0 | 0 | |||
TOP3A | 0 | 0 | |||
TP53BP1 | 0 | 0 | |||
TP63 | 0 | 0 | |||
TPM3 | 0 | 0 | |||
TRAF2 | 0 | 0 | |||
TRAF5 | 0 | 0 | |||
TRAF7 | 0 | 0 | |||
TRRAP | 0 | 0 | |||
TUBA1A | 0 | 0 | |||
TUBB | 0 | 0 | |||
TUBD1 | 0 | 0 | |||
TUBE1 | 0 | 0 | |||
TUBG1 | 0 | 0 | |||
TYK2 | 0 | 0 | |||
TYRO3 | 0 | 0 | |||
TCEB1 | 0 | 0 | |||
TACC2 | 0 | 0 | |||
TACC3 | 0 | 0 | |||
TAF15 | 0 | 0 | |||
TAF1L | 0 | 0 | |||
TAGAP | 0 | 0 | |||
TAL1 | 0 | 0 | |||
TBC1D8B | 0 | 0 | |||
TBL1XR1 | 0 | 0 | |||
TBL3 | 0 | 0 | |||
TBP | 0 | 0 | |||
TBX15 | 0 | 0 | |||
TBX22 | 0 | 0 | |||
TCERG1 | 0 | 0 | |||
TCF12 | 0 | 0 | |||
TCL1A | 0 | 0 | |||
TCP11 | 0 | 0 | |||
TDG | 0 | 0 | |||
Tec | 0 | 0 | |||
TECPR2 | 0 | 0 | |||
TENM3 | 0 | 0 | |||
TENT5C | 0 | 0 | |||
TEX12 | 0 | 0 | |||
TFDP1 | 0 | 0 | |||
TFDP2 | 0 | 0 | |||
TFG | 0 | 0 | |||
TG | 0 | 0 | |||
TGFB1 | 0 | 0 | |||
TGM2 | 0 | 0 | |||
THADA | 0 | 0 | |||
THBS1 | 0 | 0 | |||
THRAP3 | 0 | 0 | |||
THRB | 0 | 0 | |||
TIE1 | 0 | 0 | |||
TIMM8B | 0 | 0 | |||
TJP1 | 0 | 0 | |||
TLE1 | 0 | 0 | |||
TLL1 | 0 | 0 | |||
TLL2 | 0 | 0 | |||
TLX3 | 0 | 0 | |||
TMEM132D | 0 | 0 | |||
TMEM67 | 0 | 0 | |||
TMPRSS15 | 0 | 0 | |||
TNFRSF17 | 0 | 0 | |||
TNFRSF19 | 0 | 0 | |||
TNFRSF8 | 0 | 0 | |||
TNFSF13B | 0 | 0 | |||
TNK2 | 0 | 0 | |||
TNN | 0 | 0 | |||
TNPO1 | 0 | 0 | |||
TNR | 0 | 0 | |||
TNRC18 | 0 | 0 | |||
TOE1 | 0 | 0 | |||
TOP2B | 0 | 0 | |||
TOPBP1 | 0 | 0 | |||
TP73 | 0 | 0 | |||
TPH1 | 0 | 0 | |||
TPR | 0 | 0 | |||
TPX2 | 0 | 0 | |||
TRA2A | 0 | 0 | |||
TRAP1 | 0 | 0 | |||
TRERF1 | 0 | 0 | |||
TRIM24 | 0 | 0 | |||
TRIM58 | 0 | 0 | |||
TRIO | 0 | 0 | |||
TRPC5 | 0 | 0 | |||
TRPS1 | 0 | 0 | |||
TSHZ2 | 0 | 0 | |||
TSHZ3 | 0 | 0 | |||
TSN | 0 | 0 | |||
TTL | 0 | 0 | |||
TUBA3C | 0 | 0 | |||
TUBB4A | 0 | 0 | |||
TUBB4B | 0 | 0 | |||
TUBB6 | 0 | 0 | |||
TUSC3 | 0 | 0 | |||
TWIST1 | 0 | 0 | |||
TXNIP | 0 | 0 | |||
TXNRD1 | 0 | 0 | |||
TYMP | 0 | 0 | |||
TYR | 0 | 0 | |||
TYRP1 | 0 | 0 |